Skip to main content
Livermore
Livermore
ZHEN

Long Focus Capital Management, LLC

SEC CIK
0001602716
Latest filing
Aug 14, 2026

The latest 13F from Long Focus Capital Management, LLC covers Q2 2026 (filed Aug 14, 2026): 76 long positions worth $2.45B. The top 10 holdings make up 41.9% of the portfolio, and the largest is Charter Communications, Inc. (CHTR) at 7.1%. Livermore has 21 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
5
Est. +$37.2M
Added
17
Est. +$315.1M
Reduced
18
Est. −$295.2M
Sold out
13
Est. −$183.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. CHTRCharter Communications, Inc.
    7.1%$174.9MHistory
  2. AMZNAmazon Com Inc
    6.8%$167.8MHistory
  3. MOHMolina Healthcare, Inc.
    5.7%$139.5MHistory
  4. CNCCentene Corp
    3.8%$93.1MHistory
  5. CMCSAComcast Corp
    3.8%$92.9MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. CHTRCharter Communications, Inc.
    +$115.9MAddedHistory
  2. INSMINSMED Inc
    +$40.8MAddedHistory
  3. CMCSAComcast Corp
    +$37.9MAddedHistory
  4. RKTRocket Companies, Inc.
    +$33.4MAddedHistory
  5. SONYSony Group Corp
    +$19.3MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. CHTRCharter Communications, Inc.
    +3.20 pp3.9% → 7.1%History
  2. RKTRocket Companies, Inc.
    +1.42 pp2.1% → 3.5%History
  3. INSMINSMED Inc
    +1.26 pp1.0% → 2.3%History
  4. CMCSAComcast Corp
    +0.97 pp2.8% → 3.8%History
  5. SONYSony Group Corp
    +0.79 pp0.0% → 0.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. HUMHumana Inc
    −$86.0MReducedHistory
  2. CZRCaesars Entertainment, Inc.
    −$71.8MSold outHistory
  3. UNHUnitedHealth Group Inc
    −$41.6MReducedHistory
  4. VSATViasat Inc
    −$39.5MReducedHistory
  5. PENNPENN Entertainment, Inc.
    −$32.3MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CZRCaesars Entertainment, Inc.
    −3.15 pp3.1% → 0.0%History
  2. PENNPENN Entertainment, Inc.
    −1.42 pp1.4% → 0.0%History
  3. HUMHumana Inc
    −1.06 pp2.2% → 1.1%History
  4. UNHUnitedHealth Group Inc
    −0.74 pp2.2% → 1.5%History
  5. CRMSalesforce, Inc.
    −0.72 pp0.7% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$2.45B
+$173.1M (+7.6%) vs. prior quarter
Positions
76
−8 vs. prior quarter
Top 10 concentration
41.9%
Top 10 as share of value
Turnover
14.9%
Q2 2026, one quarter
Average holding period
8.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.45B (Q2 2026)

Q4 2021: $366.8MQ1 2022: $467.1MQ2 2022: $498.2MQ3 2022: $473.5MQ4 2022: $606.6MQ1 2023: $619.9MQ2 2023: $659.8MQ3 2023: $697.3MQ4 2023: $774.2MQ1 2024: $865.8MQ2 2024: $966.8MQ3 2024: $1.13BQ4 2024: $1.31BQ1 2025: $1.47BQ2 2025: $1.55BQ3 2025: $1.75BQ4 2025: $2.01BQ1 2026: $2.28BQ2 2026: $2.45B
Q4 2021Q2 2026
13F filings of Long Focus Capital Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202676$2.45BCHTRAMZNMOHvs. Q1 2026SEC
Q1 2026May 15, 202684$2.28BAMZNCHTRMOHvs. Q4 2025SEC
Q4 2025Feb 17, 202677$2.01BFTAIPYPLCHTRvs. Q3 2025SEC
Q3 2025Nov 14, 202579$1.75BFTAICHTRCNCvs. Q2 2025SEC
Q2 2025Aug 14, 202581$1.55BFTAIPYPLCMCSAvs. Q1 2025SEC
Q1 2025May 15, 202586$1.47BFTAIPYPLCMCSAvs. Q4 2024SEC
Q4 2024Feb 14, 202588$1.31BCMCSAFTAIPYPLvs. Q3 2024SEC
Q3 2024Nov 13, 2024Amended89$1.13BFTAIBABAPYPLvs. Q2 2024SEC
Q2 2024Aug 14, 202490$966.8MFTAIETARvs. Q1 2024SEC
Q1 2024May 14, 202488$865.8MFTAIARETvs. Q4 2023SEC
Q4 2023Feb 14, 202499$774.2MBABAFTAIETvs. Q3 2023SEC
Q3 2023Nov 14, 2023103$697.3MBABAETARvs. Q2 2023SEC
Q2 2023Aug 14, 2023105$659.8MFTAIARBABAvs. Q1 2023SEC
Q1 2023May 17, 2023Amended107$619.9MFTAIBABAARvs. Q4 2022SEC
Q4 2022Feb 13, 2023102$606.6MARBABAETvs. Q3 2022SEC
Q3 2022Nov 14, 2022101$473.5MARETMETAvs. Q2 2022SEC
Q2 2022Aug 12, 2022107$498.2MARBABAINTCvs. Q1 2022SEC
Q1 2022May 13, 202297$467.1MARBABAETvs. Q4 2021SEC
Q4 2021Feb 14, 202295$366.8MARMKLAGO–SEC

13D and 13G filings

Companies where Long Focus Capital Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

4 companies, largest stake first.

Companies where Long Focus Capital Management, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
BCYCBicycle Therapeutics PLC13G6.60%3.31M sharesNewMay 15, 20261 filingMay 15, 2026SEC
ONITOnity Group Inc.13G6.30%540.6K shares–Apr 29, 20224 filingsMay 15, 2026SEC
LABStandard Biotools Inc.13G6.00%23.5M sharesNewAug 14, 20261 filingAug 14, 2026SEC
SGHTSight Sciences, Inc.13G/A6.00%3.13M shares+1.00 ppfrom 5.00%Jan 23, 20252 filingsMay 15, 2025SEC

Latest filings

52 filings on file made by Long Focus Capital Management, LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Long Focus Capital Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
LABStandard Biotools Inc.Aug 14, 20266:05 AM ET13G6.00%23.5M sharesNewJun 30, 2026SEC
AURAAura Biosciences, Inc.Aug 14, 20266:05 AM ET13G4.90%5.12M shares−1.70 ppfrom 6.60%Below 5%Jun 30, 2026SEC
ONITOnity Group Inc.May 15, 20269:17 AM ET13G6.30%540.6K shares–Mar 31, 2026SEC
TLYSTilly's, Inc.May 15, 20269:16 AM ET13G0.00%0 shares−7.40 ppfrom 7.40%Below 5%Mar 31, 2026SEC
BCYCBicycle Therapeutics PLCMay 15, 20269:15 AM ET13G6.60%3.31M sharesNewMar 31, 2026SEC
ADAPYAdaptimmune Therapeutics PLCFeb 17, 20268:54 AM ET13G0.00%0 shares−8.00 ppfrom 8.00%Below 5%Dec 31, 2025SEC
FIPFTAI Infrastructure Inc.Nov 14, 20256:43 AM ET13G4.90%5.68M shares−0.10 ppfrom 5.00%Below 5%Sep 30, 2025SEC
TLYSTilly's, Inc.Nov 14, 20256:42 AM ET13G7.40%1.71M shares−2.20 ppfrom 9.60%Sep 30, 2025SEC
CTRNCiti Trends IncNov 14, 20256:38 AM ET13G2.90%242.7K shares−2.40 ppfrom 5.30%Below 5%Sep 30, 2025SEC
AZULAzul SAAug 14, 202511:40 AM ET13G0.00%0 shares–Below 5%Jun 30, 2025SEC
CTRNCiti Trends IncAug 14, 202511:33 AM ET13G5.30%440.0K shares−1.10 ppfrom 6.40%Jun 30, 2025SEC
SGHTSight Sciences, Inc.May 15, 202512:20 PM ET13G/A6.00%3.13M shares+1.00 ppfrom 5.00%Mar 31, 2025SEC
QMCOQuantum CorpMay 15, 202512:18 PM ET13G/A0.00%0 shares–Below 5%Mar 31, 2025SEC
HLFHerbalife Ltd.May 15, 202512:17 PM ET13G/A4.90%4.94M shares−0.10 ppfrom 5.00%Below 5%Mar 31, 2025SEC
HYZNHyzon Motors Inc.May 15, 202512:08 PM ET13G/A4.90%380.3K shares–Below 5%Mar 31, 2025SEC
AURAAura Biosciences, Inc.May 15, 202511:26 AM ET13G/A6.60%3.32M shares+1.60 ppfrom 5.00%Mar 31, 2025SEC
FIPFTAI Infrastructure Inc.Apr 22, 20255:31 PM ET13G5.00%5.70M sharesNewApr 14, 2025SEC
Majmudar Anang K.American Depositary Shares, each representing 1 Ordinary SharesFeb 11, 20257:11 PM ET13G/A4.60%4.62M shares–Below 5%Dec 31, 2024SEC
VINCVincerx Pharma, Inc.Feb 11, 20257:09 PM ET13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
CTRNCiti Trends IncFeb 11, 20254:44 PM ET13G/A6.40%556.5K shares–Dec 31, 2024SEC